BiotechTube
Home/Novilla Pharmaceuticals/Dr. Shashi Kori
DS

Dr. Shashi Kori

Chief Executive Officer

Novilla Pharmaceuticals

Therapeutic Areas

GoutGeneral PainDiabetic Circulatory InsufficiencyMuscle SpasmsJoint Inflammation

Novilla Pharmaceuticals Pipeline

DrugIndicationPhase
NOV-1776Not explicitly stated (likely General Pain/Joint Inflammation)Phase 2
Pipeline ProgramGoutPre-clinical

Leadership Team at Novilla Pharmaceuticals

DT
Dr. Tracey Rapp
Vice President of Product Development
AK
Ajay Kori
Managing Director
DR
Dr. Richard Tubb
Chairman of the Scientific Advisory Board
DE
Dr. Eric Fossel
CoFounder
View full Novilla Pharmaceuticals profile